These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 7643090
1. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions. Farrell CB, Lawlor M, Dunne A, O'Boyle KM. J Neurochem; 1995 Sep; 65(3):1124-30. PubMed ID: 7643090 [Abstract] [Full Text] [Related]
2. The kinetics of [3H]SCH 23390 dissociation from rat striatal dopamine D1 receptors: effect of dopamine. Farrell CB, O'Boyle KM. Eur J Pharmacol; 1994 Jun 15; 268(1):79-88. PubMed ID: 7925614 [Abstract] [Full Text] [Related]
3. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment. Srivastava LK, Ross GM, Bajwa SB, Mishra RK. Neurochem Res; 1990 Jun 15; 15(6):647-57. PubMed ID: 1977093 [Abstract] [Full Text] [Related]
4. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity. O'Boyle KM, Waddington JL. Neuropharmacology; 1992 Feb 15; 31(2):177-83. PubMed ID: 1532443 [Abstract] [Full Text] [Related]
5. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor. Niznik HB, Otsuka NY, Dumbrille-Ross A, Grigoriadis D, Tirpak A, Seeman P. J Biol Chem; 1986 Jun 25; 261(18):8397-406. PubMed ID: 3522568 [Abstract] [Full Text] [Related]
6. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase. Makman MH, Dvorkin B. Brain Res; 1986 Dec 25; 387(3):261-70. PubMed ID: 2950967 [Abstract] [Full Text] [Related]
7. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C. Proc Natl Acad Sci U S A; 1989 Dec 25; 86(24):10156-60. PubMed ID: 2574862 [Abstract] [Full Text] [Related]
8. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. West AR, Grace AA. J Neurosci; 2002 Jan 01; 22(1):294-304. PubMed ID: 11756513 [Abstract] [Full Text] [Related]
9. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Broening HW, Morford LL, Vorhees CV. Synapse; 2005 May 01; 56(2):84-93. PubMed ID: 15714503 [Abstract] [Full Text] [Related]
10. Dopamine receptors in canine caudate nucleus. Maeno H. Mol Cell Biochem; 1982 Mar 19; 43(2):65-80. PubMed ID: 6123940 [Abstract] [Full Text] [Related]
11. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site. Roseboom PH, Gnegy ME. Mol Pharmacol; 1989 Jan 19; 35(1):139-47. PubMed ID: 2563306 [Abstract] [Full Text] [Related]
12. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ, Marshall JF. Synapse; 1992 Sep 19; 12(1):14-26. PubMed ID: 1357762 [Abstract] [Full Text] [Related]
13. Altered dopamine receptor mediated signal transmission in the striatum of aged rats. May T, Sugawa M. Brain Res; 1993 Feb 26; 604(1-2):106-11. PubMed ID: 8457839 [Abstract] [Full Text] [Related]
14. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum. Dong ZJ, Chen LJ, Jin GZ, Creese I. Biochem Pharmacol; 1997 Jul 15; 54(2):227-32. PubMed ID: 9271326 [Abstract] [Full Text] [Related]
15. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K. Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7238-41. PubMed ID: 1678519 [Abstract] [Full Text] [Related]
16. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT, White FJ. Synapse; 1994 May 15; 17(1):43-61. PubMed ID: 7913772 [Abstract] [Full Text] [Related]
17. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone. Protais P, Lesourd M, Comoy E. Eur J Pharmacol; 1998 Jul 10; 352(2-3):179-87. PubMed ID: 9716353 [Abstract] [Full Text] [Related]
18. Dopamine-induced reduction in the density of guanine nucleotide-sensitive D1 receptors in human postmortem brain in the absence of apparent D1: D2 interactions. McCauley PG, O'Boyle KM, Waddington JL. Neuropharmacology; 1995 Jul 10; 34(7):777-83. PubMed ID: 8532144 [Abstract] [Full Text] [Related]
19. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively. Urwyler S, Markstein R. J Neurochem; 1986 Apr 10; 46(4):1058-67. PubMed ID: 2936868 [Abstract] [Full Text] [Related]